Enveric Biosciences Archives

Psychedelics News

Enveric Biosciences

Breaking News, Press Releases, Science

3 Jun 2025

Enveric’s Patent Win Targets New Frontiers in Sleep Medicine

With U.S. Patent No. 12,187,679 now granted, Enveric Biosciences has secured more than intellectual property—it’s staked a claim on the future of neurotherapeutics. The Cambridge-based biotech firm announced this week...

By Madison Roberts

Law & Politics

29 Nov 2023

Enveric Granted US Patent for Psilocybin Derivatives

The soon-to-issue patent contains composition of matter and methods of use claims for a family of novel prodrug derivatives of psilocybin....

By Microdose NewsDesk

Don’t Miss

22 May 2023

News You Might Have Missed: May 22nd 2023

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed....

By Microdose NewsDesk

Breaking News

18 May 2023

Enveric Biosciences Receives Patent Notice of Allowance for Novel Prodrug of Psilocin

This morning, Enveric Biosciences announced receipt of a patent allowance for Enveric's new chemical entity (NCE) psilocin prodrug being developed for the treatment of anxiety disorder....

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

11 Jul 2022

In Psychedelic Investing, Long-Term Thinking Is Key

In the fast-growing field of psychedelic medicine, long-term investing is key....

By Microdose

Don’t Miss

16 May 2022

News You Might Have Missed: May 16th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Finance

11 May 2022

Enveric to Split Into Two Companies; Spin-off Cannabinoid Pipeline

The proposed spin-off would create two separate and distinct biotechnology companies, one developing next-generation psychedelic-inspired treatments and the other developing innovative cannabinoid treatments...

By Microdose NewsDesk

Press Releases

17 Feb 2022

Enveric Biosciences and University of Calgary Collaborate on a Groundbreaking Clinical Trial for EVM-101 in Cancer Related Distress

Clinical trial aim is to include the identification and characterization of the Cancer Related Distress symptoms most responsive to psychedelic-associated therapy...

By Microdose

Press Releases

19 Jan 2022

Enveric Biosciences CEO, Dr. Joseph Tucker, Provides 2021 Year in Review and 2022 Outlook in Letter to Shareholders

Enveric launched as a patient-centric biotechnology company, employing innovation and scientific leadership as core principles....

By Microdose

Follow us on social

Latest News

Reading the Brain’s Response: Enveric’s EB-003 Takes a Step Toward Human Testing

The Cost of Waiting: What Compass’s Depression Survey Means for Psychedelic Medicine

Beyond the Psychedelic Experience: Enveric Biosciences Takes Another Step Toward a New Generation of Mental Health Treatments

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result